Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02
Charles Scott(American College of Radiology), Diana F. Nelson(Highland Hospital), Walter J. Curran(Piedmont Cancer Institute), Andreas Fischbach(LDS Hospital), James S. Nelson(University Medical Center New Orleans), Laurie E. Gaspar(University of Colorado Cancer Center), Kevin Murray(The University of Western Australia), Nancy Farnan(RTOG Foundation)
Cited by 89
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k